Up-regulation of microRNA-21 correlates with lower kidney cancer survival

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Zaman, Mohd Saif ^a   Shahryari, Varahram ^a   Deng, Guoren ^a   Thamminana, Sobha ^a   Saini, Sharonjot ^a   Majid, Shahana ^a   Chang, Inik ^a   Hirata, Hiroshi ^a   Ueno, Koji ^a   Yamamura, Soichiro ^a   Singh, Kamaldeep ^a   Tanaka, Yuichiro ^a   Tabatabai, Z Laura ^a   Dahiya, Rajvir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; GENISTEIN; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P21; MICRORNA; MIRN21 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE ARREST; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL CYCLE CHECKPOINT; CELL LINE; DRUG SCREENING; GENETICS; KIDNEY TUMOR; MORTALITY; MOUSE; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

MUS MUSCULUS;

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE; GENISTEIN; HUMANS; KIDNEY NEOPLASMS; MICE; MICRORNAS; PROGNOSIS; SURVIVAL RATE; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863393889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031060     Document Type: Article

References (44)

1. Carrington JC, Ambros V, (2003) Role of microRNAs in plant and animal development. Science 301: 336-338.
2. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
3. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
4. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297: 1901-1908.
5. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, et al. (2008) E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286.
6. Avery AK, Beckstead J, Renshaw AA, Corless CL, (2000) Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 24: 203-210.
7. Chow GK, Myles J, Novick AC, (2001) The Cleveland Clinic experience with papillary (chromophil) renal cell carcinoma: clinical outcome with histopathological correlation. Can J Urol 8: 1223-1228.
8. Thoenes W, Storkel S, Rumpelt HJ, (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181: 125-143.
9. Jayson M, Sanders H, (1998) Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51: 203-205.
10. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, et al. (2009) MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 35: 109-114.
11. Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, et al. (2008) Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 216: 418-427.
12. Juan D, Alexe G, Antes T, Liu H, Madabhushi A, et al. (2010) Identification of a microRNA panel for clear-cell kidney cancer. Urology 75: 835-841.
13. Chen J, Jackson PK, Kirschner MW, Dutta A, (1995) Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374: 386-388.
14. Luo Y, Hurwitz J, Massague J, (1995) Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375: 159-161.
15. Selcuklu SD, Donoghue MT, Spillane C, (2009) miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 37: 918-925.
16. Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, et al. (2000) Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A 97: 4291-4296.
17. Delavaine L, La Thangue NB, (1999) Control of E2F activity by p21Waf1/Cip1. Oncogene 18: 5381-5392.
18. Coqueret O, Gascan H, (2000) Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J Biol Chem 275: 18794-18800.
19. Kitaura H, Shinshi M, Uchikoshi Y, Ono T, Iguchi-Ariga SM, et al. (2000) Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J Biol Chem 275: 10477-10483.
20. Lohr K, Moritz C, Contente A, Dobbelstein M, (2003) p21/CDKN1A mediates negative regulation of transcription by p53. J Biol Chem 278: 32507-32516.
21. Taylor WR, Stark GR, (2001) Regulation of the G2/M transition by p53. Oncogene 20: 1803-1815.
22. Gottifredi V, Karni-Schmidt O, Shieh SS, Prives C, (2001) p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Mol Cell Biol 21: 1066-1076.
23. Roninson IB, (2002) Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179: 1-14.
24. Kaneuchi M, Yamashita T, Shindoh M, Segawa K, Takahashi S, et al. (1999) Induction of apoptosis by the p53-273L (Arg->Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax. Mol Carcinog 26: 44-52.
25. Okaichi K, Wang LH, Sasaki J, Saya H, Tada M, et al. (1999) A point mutation of human p53, which was not detected as a mutation by a yeast functional assay, led to apoptosis but not p21Waf1/Cip1/Sdi1 expression in response to ionizing radiation in a human osteosarcoma cell line, Saos-2. Int J Radiat Oncol Biol Phys 45: 975-980.
26. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, et al. (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8: 781-794.
27. Gartel AL, (2005) The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis. Leuk Res 29: 1237-1238.
28. Magee PJ, Rowland IR, (2004) Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91: 513-531.
29. Bektic J, Guggenberger R, Eder IE, Pelzer AE, Berger AP, et al. (2005) Molecular effects of the isoflavonoid genistein in prostate cancer. Clin Prostate Cancer 4: 124-129.
30. Hunter T, (1987) A thousand and one protein kinases. Cell 50: 823-829.
31. Ullrich A, Schlessinger J, (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212.
32. Zava DT, Duwe G, (1997) Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27: 31-40.
33. Day JK, Bauer AM, DesBordes C, Zhuang Y, Kim BE, et al. (2002) Genistein alters methylation patterns in mice. J Nutr 132: 2419S-2423S.
34. Hillman GG, Wang Y, Che M, Raffoul JJ, Yudelev M, et al. (2007) Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model. BMC Cancer 7: 4.
35. Eulalio A, Huntzinger E, Izaurralde E, (2008) Getting to the root of miRNA-mediated gene silencing. Cell 132: 9-14.
36. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
37. Cai X, Hagedorn CH, Cullen BR, (2004) Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10: 1957-1966.
38. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261.
39. Chan JA, Krichevsky AM, Kosik KS, (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
40. Si ML, Zhu S, Wu H, Lu Z, Wu F, et al. (2007) miR-21-mediated tumor growth. Oncogene 26: 2799-2803.
41. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
42. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, et al. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136.
43. Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, et al. (2007) Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110: 1330-1333.
44. Zhang A, Liu Y, Shen Y, Xu Y, Li X, (2011) miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma. Urology 78: 474 e13-9.